News

Since August 2026, Stefanie Seltmann has headed our new Data, Information and Publication Services department. In this interview, she explains what her team does and why our researchers, and science as a whole, stand to benefit.

Immunotherapies strengthen the body’s own anti-cancer defenses in a highly targeted manner. In...

Around 65 group leaders and PIs have gone through a new instrument developed as part of Strategy 2030: the 360° leadership feedback process. An interview with Group Leader and Associate Director of Talent Management Katja Simon on how to give and receive feedback.

Marie Skłodowska-Curie Actions Postdoctoral Fellowships are intended to support careers, foster research excellence, and provide international and interdisciplinary advanced training through cross-border mobility. Sara De Vincentiis in the Gouti lab is among this year’s winners.

Nikolaus Rajewsky and his team have built a search engine that can scan data from millions of single cells from thousands of experiments worldwide in seconds. The tool, described in “Nature,” makes it possible to answer previously impossible questions about RNA biology.

A seven protein “signature” in blood can indicate successful treatment for vasculitis. The Mertins, Forslund and Kettritz labs report in “Nature Communications” how they used proteomics and AI to identify biomarkers, which could enable more personalized treatment with fewer side effects.

One week, two topics, and plenty of new experiences: 25 young people take a deep dive into research on rare diseases and immunology at the Life Science Learning Lab “Gläsernes Labor,” including by analyzing their own genes.

As of August 15, 2026, Kirstin Bodensiek has officially taken the helm as Administrative Director of the Max Delbrück Center. She is stepping into the permanent position after leading the center on an interim basis.

The German Stem Cell Network is honoring Maike Sander with a Hilde Mangold Award. The network recognized Sander for her scientific excellence, outstanding scientific leadership, and impact as a role model for women in research.

Bringing a new CAR-T cell therapy from promising results in the lab to critically ill cancer patients is anything but straightforward. A Tagesspiegel podcast featuring, among others, Armin Rehm explores the hurdles that must be overcome along the way and why the process is often faster in the United States.